Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study. https://t.co/dgMeGHDkHf
RT @NDTsocial: Clinical adjudication in acute #kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 #biomarker study https://t.co…
Clinical adjudication in acute #kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 #biomarker study https://t.co/gXAfJKd80d https://t.co/Z1EcL07RGI
@NDTsocial high scoring article on the clinical adjudication in #AcuteKidneyInjury studies https://t.co/wUjnRASlT2 https://t.co/MhVQNkCLQh
Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2... https://t.co/qhLQLLtLa4 https://t.co/KahlaPxq46
Explore the benefits and #risks of biomarkers in predicting AKI in critically #ill patients https://t.co/7lbjFTD6sv https://t.co/xah31aMGco
RT @ASPNeph: Clinical adjudication in #AKI studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study https://t.co/Ndw6WBuLQr @NDTso…
RT @ASPNeph: Clinical adjudication in #AKI studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study https://t.co/Ndw6WBuLQr @NDTso…
Clinical adjudication in #AKI studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study https://t.co/Ndw6WBuLQr @NDTsocial